2018 Speakers

 

Advanced Therapies & Regenerative Medicine Featured Speakers

Frédéric Triebel, CSO & CMO, Prima Biomed, Ltd

Frédéric Triebel , CSO & CMO, Prima Biomed

Margo Roberts, CSO, Kite Pharma

Margo Roberts, CSO, Kite Pharma

Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation

Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Stephen Badylak, Professor, Department of Surgery, Director, Center for Pre-Clinical Tissue Engineering, Deputy Director, McGowan Institute for Regenerative Medicine (MIRM)

Stephen Badylak,  Professor, Department of Surgery, Director, Center for Pre-Clinical Tissue Engineering, Deputy Director,  McGowan Institute for Regenerative Medicine (MIRM)

Keith Thompson, CEO, Cell and Gene Therapy Catapult

Keith Thompson CEO, Cell and Gene Therapy Catapult

Xiaobin Victor Lu, CMC Reviewer, CBER, Office of Tissues and Advanced Therapies, Division of Cellular and Gene Therapies, U.S. Food and Drug Administration

Xiaobin Victor Lu, CMC Reviewer, CBER, Office of Tissues and Advanced Therapies, Division of Cellular and Gene Therapies, U.S. Food and Drug Administration

Jon Wigginton, Chief Medical Officer and Senior Vice-President, Clinical Development, MacroGenics

Jon Wigginton, Chief Medical Officer and Senior Vice-President, Clinical Development, MacroGenics

 

Cord Blood Featured Speakers

Elizabeth Shpall, Director, MD Anderson Cancer Center

Elizabeth Shpall, Director, MD Anderson Cancer Center 

Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University

Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University

Todd McAllister, Executive Director, Amnion Foundation

Todd McAllister, Executive Director, Amnion Foundation

Colleen Delaney, Founder and Chief Medical Officer, Nohla Therapeutics

Colleen Delaney, Founder and Chief Medical Officer, Nohla Therapeutics

 

Precision Medicine Featured Speakers

Sue Hill, Chief Scientific Officer,  NHS

Sue Hill, Chief Scientific Officer,  NHS

Joanne Hackett, Chief Commercial Officer, Genomics England

Joanne Hackett, Chief Commercial Officer, Genomics England

Julia Wilson, Associate Director, Wellcome Trust Sanger Institute

Julia Wilson, Associate Director, Wellcome Trust Sanger Institute

Paul P. Tak, Academic Medical Centre, University of Amsterdam; Senior Vice President of Research & Development Pipeline, Chief Immunology Officer, GSK

Paul P. Tak, Academic Medical Centre, University of Amsterdam; Senior Vice President of Research & Development Pipeline, Chief Immunology Officer, GSK

 

Ai In Healthcare Featured Speakers

Ian Abbs, Chief Medical Officer,  Guys’ and St. Thomas’ NHS Foundation Trust

Ian Abbs, Chief Medical Officer,  Guys’ and St. Thomas’ NHS Foundation Trust

Milind Kamjolar, Chief Data Officer, Sanofi

Milind Kamjolar, Chief Data Officer, Sanofi

Patrick Keohane, Chief Medical Officer, BenevolentAI

Patrick Keohane, Chief Medical Officer, BenevolentAI

Juergen Hammer, Global Head, Data Science, Roche

Juergen Hammer, Global Head, Data Science, Roche

 

 

Speakers Listed Alphabetically

Farooq Abbasi, Associate Partner, Mosaic Ventures

Farooq Abbasi at World Advanced Therapies & Regenerative Medicine Congress

Jeffrey D Abbey, President and Chief Executive Officer, Argos Therapeutics

Ian Abbs, Medical Director, Guy’s and St Thomas N.H.S Foundation Trust

Ian Abbs at World Advanced Therapies & Regenerative Medicine Congress

Zami Aberman, Chairman and Chief Executive Officer, Pluristem

Mayur Abhaya, Managing Director and Chief Executive Officer, Lifecell Ltd

Dionisio Acosta, Director, Graduate Programme, Health Informatics, UCL

Dr Bissan Al Lazikani, Head of Data Science, Institute of Cancer Research

Ronald Alfa, Director of Translational Biology, Recursion Pharmaceuticals

Dr Ana Alfirevic, Senior Lecturer, University of Liverpool

Dr Ana Alfirevic at World Advanced Therapies & Regenerative Medicine Congress

Rob Allen, Senior Director, Immunotherapy Programme, Asterias Biotherapeutics INC.

Brandon Allgood, Chief Technology Officer, Numerate Inc

Gil Alterovitz, Director, Biomedical Cybernetics Laboratory Computational Health Informatics Program, Harvard Medical School Department of Biomedical Informatics

Gil Alterovitz at World Advanced Therapies & Regenerative Medicine Congress

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Stephen Badylak, Deputy Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh

Stefano Baila, Director of Operations & Business Development, Anemocyte

Ameet Bakhai, Consultant Cardiologist Heart Failure Lead Barnet, Barnet and Chase Farm N.H.S. Trust Amore Health Ltd

Pedro Ballester, Group Leader, INSERM

Natalie Banner, Policy Adviser, Wellcome Trust

Dr Rosemary Barber, Honorary Senior Research Fellow, University of Sheffield

Marion Bartel, Project Manager, Vita34

Jeffrey Bartlett, SVP R&D, Calimmune

Jeffrey Bartlett at World Advanced Therapies & Regenerative Medicine Congress

Domenick Bertelli, Partner, Putnam Associates

Domenick Bertelli at World Advanced Therapies & Regenerative Medicine Congress

Karina Bienfait, Principal Scientist and Head, Global Genomics Policy, Process and Compliance, MSD

Theo Blackwell, Chief Digital Officer, Mayor of London

Wen Bo Wang, Senior Vice President Of Cell Therapy Research And Development, Cellular Dynamics International Inc.

Eerke Boiten, Professor of Cyber Security, De Montfort University

Veronique Bouchet, Chief Medical Officer, Row Analytics

Amelie Boulais, Vaccine Platform Marketing Manager, Sartorius Stedim Biotech

Amelie Boulais at World Advanced Therapies & Regenerative Medicine Congress

Mark Braganza, Executive Partner, GHO Capital Partners

Leigh Brody, Director Of Genomic Services, Celixir

Krishna Bulusu, Senior Scientist, Oncology Bioinformatics, AstraZeneca

Mitchell Cairo, ‌Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation‌, New York Medical College

Didier Caizergues, Director of Regulatory Affairs, Genethon

John Campbell, Professor and Associate Director, Scottish National Blood Transfusion Service

Manuel Carrondo, Vice President, IBET

Victoria Cetinkaya, Senior Policy Officer, Policy & Engagement, Information Commissioners Office

Jennifer Cham, Lead User Experience Designer, EMBL-EBI

Benoit Champluvier, Chief Technology And Manufacturing Officer, Bone Therapeutics

Benoit Champluvier at World Advanced Therapies & Regenerative Medicine Congress

Maria Chatzou, Co-founder & Senior Advisor, Innovation Forum

Wei Yi Cheng, Data Scientist, Roche Innovation Center New York

Dr Yen Choo, Chief Executive Officer, Progenitor Therapeutics

Veronique Chotteau, Principal Investigator, K.T.H. Royal Institute of Technology

Dr Andre Choulika, Chairman & Chief Executive Officer, Cellectis

Bonny Chow, Stem Cell Programme Manager, HKCE

David Cole, Head Innovation Lead, Europe, IBM Watson Health

Charles Cox, Head of Pharmacogenetics, Genetics, Target Sciences, GSK R&D

Nick Crabb, Programme Director – Scientific Affairs, NICE

Maria Craig, Professor of Paediatric Endocrinology, The University of Sydney

Dr Salmaan Dalvi, Director Stem Cells Programme, Precious Cells Miracle

Francesco Dazzi, Professor of Regenerative and Hematological Medicine, King's College London

Theresa Deisher, President & Chief Executive Officer, AVM Biotechnology, LLC

Dr Colleen Delaney, Chief Medical Officer, Nohla Therapeutics

Kumar Dhanasekharan, Senior Director and Head of Biologics Process and Analytical Development, Amicus Therapeutics Inc

Jane Dunnage, Patient and Public Involvement lead, MASTERPLANS Consortium

Matthew Durdy, Chief Business Officer, Cell and Gene Therapy Catapult

Elliott Engers, CEO & Co-Founder, Infinity Health

Jim Fackler, John Hopkins School Of Medicine

Kate Falcon Girard, Program Manager of Regenerative Medicine, PerkinElmer Diagnostics ViaCord

Dr Suzanne Farid, Biochemical Engineering Professor, University College London

Saman Farid, Head, Baidu Ventures USA

Wildon Farwell, Senior Director, Late Stage Clinical Development, Biogen

Laura Ferraiuolo, Lecturer in Translational Neurobiology, University of Sheffield

Paul Firuta, Chief Commercial Officer, uniQure

Warachaya Fongsarun, Medical Director, THAI StemLife Co.,Ltd.

John Fox, Professor, Oxford University

Isabel Fox, Head of Venture Capital, White Cloud Capital Advisors

Tony Freemont, Director, MMPathIC, The University of Manchester

Tony Freemont at World Advanced Therapies & Regenerative Medicine Congress

Maya Furstenau Sharp, Marketing Manager for Regenerative Medicine, Sartorius

Steve Gardner, CEO, RowAnalytics

Steve Gardner at World Advanced Therapies & Regenerative Medicine Congress

Darren Gates, Paediatric Intensivist / Innovation Consultant, Alder Hey Childrens N.H.S. Foundation Trust

Nophar Geifman, Lecturer in Biomedical Data Analysis and Modelling, The University of Manchester

Pantelis Georgiou, Reader in Biomedical Electronics, Department of Electrical and Electronic Engineering, Imperial College London

Arezou Ghazani, Dr, Harvard Medical School

Cédric Ghevaert, Senior Lecturer Transfusion Medicine, University of Cambridge

Brian Goldman, Research Fellow II, Vertex Pharmaceuticals

Dr Andre Gomes, CEO, STEMLAB

Dr Andre Gomes at World Advanced Therapies & Regenerative Medicine Congress

Jay Goth, Managing Partner, Forentis Fund

Prof Gerard Graham, Professor of Molecular and Structural Immunology, The University of Glasgow

Tim Guilliams, CEO, Healx

Pascale Guillot, Senior Lecturer of Fetal and Maternal Health, University College London

Rajeev Gupta, Senior Lecturer, Haematology, UCL Cancer Institute

Miriam Haak, Manager Business Development, Miltenyi Biotec GmbH

Thomas Hach, Director HCS, Novartis

Joanne Hackett, Chief Commercial Officer, Genomics England

Jennifer Hall, Chief, Institute for Precision Cardiovascular Medicine, American Heart Association

Joshua Hare, Director of Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine

Karen Harrison, Support Services Manager, ALD Life

Hansjörg Hauser, Head of Dept. of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Frank Hecht, Vice President Marketing and Sales, CellGenix GmbH

Enrico Heffler, Assistant Professor in Respiratory Medicine; Personalized Medicine, Asthma & Allergy Unit, Humanitas University

Abraham Heifets, Chief Executive Officer, Atomwise Inc

Hatim Hemeda, CEO, PL BioScience GmbH

Diana Hernandez, Anthony Nolan

Antoine Heron, Stem Cell Bioprocessing Group, Merck Group

Pau Herrero Vinas, Research Fellow, Department of Electrical & Electronic Engineering, Imperial College London

Sue Hill, CSO, NHS England

Nathan Hill, Outcomes Research Scientist, Innovative Medicine (Cardiovascular & Immunology), Bristol Myers Squibb

Dr Ian Hudson, Chief Executive Officer, Medicines and Healthcare Products Regulatory Agency

Stuart Hughes, Director and Head of Pharmacology, Vertex Pharmaceuticals

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Anu Jalanko, Research Manager, National Institute for Health and Welfare, Helsinki and FinnGen Project Manager, Institute for Molecular Medicine Finland (FIMM)

Ansar Jawaid, Founder and Chief Executive Officer, Precision Medicines

Dylan Jones, Principal Scientist, Sanofi

Thomas Kaier, British Heart Foundation Research Fellow, Specialist Registrar in Cardiology, King's College London

Melpomeni Kalofonou, Postdoctoral Researcher (Cancer Technology Lead), Imperial College London

Dipak Kalra, President, The European Institute for Innovation through Health Data

Dmitry Kaminskiy, Founding Partner, Deep Knowledge Ventures

Milind Kamkolkar, Chief Data Officer, Sanofi

Milind Kamkolkar at World Advanced Therapies & Regenerative Medicine Congress

Dr Bo Kara, Head Process Development, GlaxoSmithKline

Ohad Karnieli, Chief Executive Officer and Co Founder, Atvio Biotechnology

Cornelia Kasper, Professor, Biopharmaceutical Production and Technology, B.O.K.U.

Patrick Keenan, Managing Director, Prevail Partners

Thomas Keller, Sr. Director and GSK Fellow, GSK

Alastair Kent OBE, Retired

Patrick Keohane, Chief Medical Officer, Benevolent A.I.

Patrick Keohane at World Advanced Therapies & Regenerative Medicine Congress

Aisha Khan, Executive Director of Laboratory Operations, Interdisciplinary Stem Cell Institute

Dr Michael Kiebish, Chief Precision Medicine Officer, Berg Co Ltd

Dr Michael Kiebish at World Advanced Therapies & Regenerative Medicine Congress

Helene Faustrup Kildegaard, Senior Researcher and Co PI, Technical University of Denmark

Helene Faustrup Kildegaard at World Advanced Therapies & Regenerative Medicine Congress

Helena Kilpinen, GOS Institute of Child Health, UCL Great Ormond Street Institute of Child Health

Nikole Kimes, Co-Founder and Executive Vice President, Siolta Therapeutics

Evangelos Kiskinis, Director Stem Cell Core Facility Co-Director, Stem Cell and Regenerative Biology, Northwestern University

Nancy Krunic, VP, Global Head of Future Precision Medicine, Novartis Oncology

Dr Joanne Kurtzberg, Director, Carolinas Cord Blood Bank At Duke

Jean-Pierre Latere, COO, Celyad

Holger Laux, Fellow, Novartis Pharma

Stanley Lazic, Associate Director, Statistics & Machine Learning, AstraZeneca

Christophe Le Tourneau, Head of Clinical Research, Department of Medical Oncology, Curie Institute

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

James Leverone, Senior Engineer and lead of the Process Validation and Engineering group, ImmunoGen Inc

Pei-Yi Lin, Senior Scientist, Thermo Fisher

Michael Linden, VP Gene Therapy & Head, GMI, Pfizer Ltd

Cecilia Lindskog, Director Tissue Atlas, Human Protein Atlas, Uppsala University

Cecilia Lindskog at World Advanced Therapies & Regenerative Medicine Congress

Giovanna Lombardi, Professor of Human Transplant Immunobiology, King's College London

Xiaobin Victor Lu, Biologist, Gene Therapy Branch , Division of Cellular and Gene Therapies , OCTGT, FDA CBER

Paul Lucas, Director of Orthopaedic Research, Department of Orthopaedic Surgery, New York Medical College

Paul Lucas at World Advanced Therapies & Regenerative Medicine Congress

Anneke Lucassen, Professor of Clinical Genetics, University Of Southampton

Philipp M Diesinger, Global Head of Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Kath Mackay, Deputy Director Ageing Society, Health & Nutrition, Innovate UK

Dr Danilo Maddalo, Laboratory Head, Novartis Institutes for Biomedical Research

John Madsen, Head of Process Development Operations, Fujifilm Diosynth Biotechnologies Texas

John Maher, Chief Scientific Officer, Leucid Bio

Shrikant Mane, Director, Yale Center for Genome Analysis

Rachel Manley, Head of Global Outreach, Save the Cord Foundation

Rachel Manley at World Advanced Therapies & Regenerative Medicine Congress

Chris Mansi, Viz.Ai

Yael Margolin, Chief Executive Officer, Gamida Cell Ltd

Dr Irene Martini, Lecturer, University La Sapienza

Fernanda Masri, Account Manager BPS, Sartorius Corporate Administration GmbH

Fernanda Masri at World Advanced Therapies & Regenerative Medicine Congress

Hector Mayani, Head, Oncology Research Unit, Cordon Vital SA de CV

Julio Mayol, Hospital Clinico San Carlos

Julio Mayol at World Advanced Therapies & Regenerative Medicine Congress

Giuseppe Mazza, Chief Executive & Scientific Officer, Engitix

Dr Todd McAllister, Executive Director, Amnion Foundation

Ian McKay, ‎Innovation Lead Advanced Therapies, Innovate UK

Ian McKay at World Advanced Therapies & Regenerative Medicine Congress

Nick Medcalf, Innovation Lead - Advanced Therapies, Innovate UK

Nick Medcalf at World Advanced Therapies & Regenerative Medicine Congress

Paula Meleady, Associate Director, National Institute for Cellular Biotechnology

Michael Menden, Senior Scientist, AstraZeneca

Stefano Menegatti, Assistant Professor in Chemical and Biomolecular Engineering, North Carolina State University

Otto Wilhelm Merten, Head of Applied Vectorology and Innovation group, Genethon

Pierre Meulien, Executive Director, Innovative Medicines Initiative

Filippo Milano, Associate Director Cord Blood Transplantation, Fred Hutchinson Cancer Research Center

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller at World Advanced Therapies & Regenerative Medicine Congress

Adele Mitchell, Associate Director, Discovery Data Science, Eisai Inc

Adele Mitchell at World Advanced Therapies & Regenerative Medicine Congress

Massimo Morbidelli, Professor of Chemical and Bioengineering, E.T.H. Zurich

Sue Mundy, Head of Cord Blood Collection, Anthony Nolan

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Prof Norio Nakatsuji, Chief Advisor, Kyoto University

Niven Narain, Co-Founder, President & CEO, Berg Co Ltd

Niven Narain at World Advanced Therapies & Regenerative Medicine Congress

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

James Noble, Chief Executive Officer, Adaptimmune Ltd

Everson Nogoceke, Biomarker and Experimental Medicine Leader, F.Hoffmann-La Roche

Jelena Ochs, Head of the Business Unit for Life Sciences Engineering, Fraunhofer Institute for Production Technology

Jelena Ochs at World Advanced Therapies & Regenerative Medicine Congress

George Okafo, Senior Director, In-Silico Drug Discovery Unit, GSK

Eduardo Olavarria, BMT Program Director, Consultant Haematologist, Imperial College Healthcare Nhs Trust

Prof Peder Olofsson, Founding Director, Karolinska University Hospital

Prof Peder Olofsson at World Advanced Therapies & Regenerative Medicine Congress

Hiromu Ozaki, General Manager of Business Development Division, Healios K. K.

William Paiva, Executive Director, Center for Health Systems Innovation, Oklahoma State University

Mene Pangalos FRSB FMedSci, Executive Vice President, IMED Biotech Unit & Global Business Development, AstraZeneca

Helen Papadaki, Professor of Haematology, School of Medicine, University of Crete, Head of the Department of Haematology, Public Cord Blood Bank of Crete

Ioannis Papantoniou, ATMP Bioprocessing Coordinator, KU Leuven

Ioannis Papantoniou at World Advanced Therapies & Regenerative Medicine Congress

Georgia Papathomas, SVP, Global Head Data Sciences, Johnson & Johnson

Biju Parekkadan, Co Founder, Sentien Biotechnologies

Baiju Parikh, Global Sales Lead, Watson for Genomics, IBM Watson Health

Prof. Michael Parker, Professor of Bioethics and Director of the Wellcome Centre for Ethics and Humanities, University of Oxford

Detlev Parow, Head of Department of Medicines, Therapeutic Appliances and Remedies, D.A.K.

Vivienne Parry, Head of Engagement, Genomics England

Vivienne Parry at World Advanced Therapies & Regenerative Medicine Congress

David Pearce, Executive Vice President of Innovation and Research, Sanford Research

Niels Peek, Professor, Greater Manchester Connected Health City

Niels Peek at World Advanced Therapies & Regenerative Medicine Congress

Amnon Pelz, CEO, Taburit

Marc Penn, Director, Research and Development, Okyanos Cell Therapy

Brad Perkins, Chief Medical Officer, Human Longevity Inc

Brad Perkins at World Advanced Therapies & Regenerative Medicine Congress

Dr Andrea Piccin, Consultant Haematologist,Transfusion Service, San Maurizio, Bolzano

Sergey Piletsky, Professor, University of Leicester

Dr Mehis Pilv, CEO and Business Development, GeneCode Ltd

Dr Mehis Pilv at World Advanced Therapies & Regenerative Medicine Congress

Jef Pinxteren, VP Operations, Promethera Bioscience

Sarah Pitluck, Head, Global Pricing & Reimbursement, Spark Therapeutics

Sarah Pitluck at World Advanced Therapies & Regenerative Medicine Congress

Martin Pöhlchen, Partner, Alira Health

Kay Poulton, Director, Transplantation Laboratory, Manchester Royal Infirmary

Sudhakaran Prabakaran, Lecturer, Department of Genomics, University of Cambridge

Chiranya (Anjie) Prachaseri, Chief Executive Officer, South East Asia, Cryoviva

Dr Robert Preti, CEO & President, Hitachi Chemical Advanced Therapeutics Solutions, LLC

Vaclav Prochazka, Vice director for R and D, University hospital Ostravs

Andrew Quick, Product Manager, Entegris Inc

Andrew Quick at World Advanced Therapies & Regenerative Medicine Congress

Dr Qasim Rafiq, Associate Professor, Bioprocessing of Cell and Gene Therapies, University College London

Kavita Raj, Consultant Haematologist, Guy's And St Thomas' Hospital

Kavita Raj at World Advanced Therapies & Regenerative Medicine Congress

Janette Rawlinson, Governance Board Member, Stratified Medicine Programme, Cancer Research UK

Daniel Ray, Director of Data, NHS Digital

Ajan Reginald, CEO, Celixir

Ajan Reginald, CEO, Celixir

Joachim Reischl, VP, Head Precision Medicine Policy, Portfolio and Externalisation, AstraZeneca

Maria Rende, Sales Specialist, Maco Pharma

Katy Rezvani, Chief, Section of Cellular Therapy, MD Anderson Cancer Center

Dr Margo R. Roberts, Chief Scientific Officer, Kite Pharma Inc

Scott Robinson, Chief Science Officer, MicroQuin

Payal Roychoudhury, Field Applications Scientist, EU, MaxCyte

Joni Rutter, Director of Scientific Programs, All of Us Research Proframme, Precision Medicine Initiative, National Institutes of Health

Riccardo Sabatini, Co-Founder, Chief Data Officer, Orionis Biosciences

Paula Salmikangas, Director for Biopharmaceuticals & ATMPs, N.D.A. Regulatory Advisory Board

Rocio Salvador Roldan, Policy Officer of D.G. Health, European Commission

Gregg Sando, Founder and Chief Executive Officer, Cell Medica Ltd

Rangaprasad Sarangarajan, Senior Vice President & Chief Scientific Officer, BERG Health

Rangaprasad Sarangarajan at World Advanced Therapies & Regenerative Medicine Congress

Rangaprasad Sarangarajan, Senior Vice President & Chief Scientific Officer, BERG Health

Rangaprasad Sarangarajan at World Advanced Therapies & Regenerative Medicine Congress

Mark W. Sawicki, Ph.D, Chief Commercial Officer, Cryoport Inc

Matthieu-P. Schapranow, Program Manager E-Health & Life Sciences, Hasso Plattner Institute

Ernesto Scibona, Doctoral student, E.T.H. Zurich

Ernesto Scibona at World Advanced Therapies & Regenerative Medicine Congress

Nigel Scott, Global Head of Regulatory Affairs, Celixir

Nigel Scott at World Advanced Therapies & Regenerative Medicine Congress

Rameen Shakur MD PhD(Cantab) FRSA, Wellcome Trust Academic Cardiology, University of Cambridge

Gocha Shatirishvili, MD, PhD, Medical Director, Geocord, Geocord, Farmax Ltd

Jacqui Shaw, Professor of Translational Cancer Genetics, University of Leicester

Jacqui Shaw at World Advanced Therapies & Regenerative Medicine Congress

Benjamin Shepherd, Associate Director of R&D, Therapeutics, Organovo

Ursula Simon, pHD Student, University of Edinburgh

Ursula Simon at World Advanced Therapies & Regenerative Medicine Congress

David Sloman, Chief Executive Officer, Royal Free London N.H.S. Foundation Trust

David Sloman at World Advanced Therapies & Regenerative Medicine Congress

Sam Smith, Co-ordinator, MedConfidential

Roger Smith, Professor of Equine Orthopaedics, Royal Veterinary College

David Smith, Professor of Laboratory Medicine And Pathology, Mayo Clinic

David Smith, Head of Innovation and Engineering, Hitachi Chemical Advanced Therapeutics Solutions, LLC

David Smith at World Advanced Therapies & Regenerative Medicine Congress

Kate Sneddon, CEO, Biovault Technical Ltd

Michael Sokolov, PhD Candidate, E.T.H. Zurich

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Eric Soller at World Advanced Therapies & Regenerative Medicine Congress

Susan L. Solomon, Chief Executive Officer and Co-Founder, New York Stem Cell Foundation

Christos Sotirelis, Patient Representative, EURORDIS European Organisation for Rare Diseases

Dr Oliver Spadiut, Group Leader of Integrated Bioprocess Development, Vienna University of Technology

Dr Glyn Stacey, Executive Director, International Stem Cell Banking Initiative

Kari Stefansson, Chief Executive Officer, Decode Genetics

Michael Stein, Chief Executive Officer, Oxstem

Alan Stokes, COO and Chartered Insurer, Future Family

Marko Strbad, Chief Executive Officer, Biobanka Ltd

Marko Strbad at World Advanced Therapies & Regenerative Medicine Congress

Sumi Subramaniam, Programme Manager, Precision Medicine, Research & Innovation, Cancer Research UK

Casey Swerner, Investor, Dn Capital

Paul Peter Tak, Senior Vice President, Immunology Network, GSK

Paul Peter Tak at World Advanced Therapies & Regenerative Medicine Congress

Paul Peter Tak, Senior Vice President, Immunology Network, GSK

Dr Helen Tayton-Martin, Chief Business Officer, Adaptimmune Llc

Alain Thierry, Director of Research, INSERM

Amy Thomas, Head of Regulatory Development, Human Tissue Authority

Amy Thomas at World Advanced Therapies & Regenerative Medicine Congress

Keith Thompson, Chief Executive Officer, Cell and Gene Therapy Catapult

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Prima Biomed, Ltd

Allan Tucker, Senior Lecturer, Head of Intelligent Data Analysis Group, Brunel University

Lizzie Tuckey, Director of Clinical Strategy, Bupa

Marc Turner, Medical Director, Scottish National Blood Transfusion Service

Seshadri Vasan, Honorary Visiting Professor of Health Sciences, University of York, Senior Business Development Manager, Public Health England

Alain Vertes, Managing Director, NxR Biotechnologies

Dr Ivan Wall, Reader in Department of Biochemical Engineering, University College London

Dr Ivan Wall at World Advanced Therapies & Regenerative Medicine Congress

Jonas Wang, Chief Executive Officer/Chariman, StemCyte International

Dr Mark Watson, Head of Programmes, Clinical Research Development Ireland

Dr Michael D West, Ph.D., Chief Executive Officer and Director, BioTime, Inc.

Tony Whetton, Director, Stoller Biomarker Discovery Centre

Dr Jon Wigginton, Chief Medical Officer, MacroGenics, Inc.

Julia Wilson, Associate Director, Wellcome Trust Sanger Institute

Mathew Woodwark, Director of Research Bioinformatics, Medimmune Ltd

David Johannes Wurm, Project Assistant of Biochemical Engineering, Vienne University of Technology

David Johannes Wurm at World Advanced Therapies & Regenerative Medicine Congress

Marijke Wynants, MSAT Lead, Sanofi

Marijke Wynants at World Advanced Therapies & Regenerative Medicine Congress

Hakim Yadi, CEO, Northern Health Science Alliance

Hakim Yadi at World Advanced Therapies & Regenerative Medicine Congress

Zachary Yerushalmi, Oxford Sciences Innovation

Zachary Yerushalmi at World Advanced Therapies & Regenerative Medicine Congress

Simon Young, Director - Respiratory Precision Medicine, AstraZeneca U.K. Ltd

Alex Zhavoronkov, CEO, Insilico Medicine, Inc

Dr Mark Zimmerman, Vice President, Business Development and Strategy, ViaCyte

Josefin Zschaler, Project Manager, Vita34

 

DOWNLOAD BROCHURE

 

  World Advanced Therapies & Regenerative Medicine Congress  

 

The World Advanced Therapies and Regenerative Medicine Congress, co-located with the World Precision Medicine Congress is two events: A world-class conference where business leaders from around the world meet; and, a unique exhibition for pharma, biotech and research experts. To visit the exhibition is free. There is, naturally, a registration fee to attend the conference.

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com